Chengdu Kanghua Biological's low P/E ratio, poor earnings and projected growth below market average may impact future share price. A significant rise in share price is unlikely in the near future.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more